Adrenocortical carcinoma historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 8: Line 8:
==Historical perspective==
==Historical perspective==
* In 1811, an association of [[virilization]] and an [[adrenal tumor]] found at [[autopsy]] was first observed.
* In 1811, an association of [[virilization]] and an [[adrenal tumor]] found at [[autopsy]] was first observed.
* <ref name="pmid8661638">{{cite journal| author=Welbourn RB| title=Highlights from endocrine surgical history. | journal=World J Surg | year= 1996 | volume= 20 | issue= 5 | pages= 603-12 | pmid=8661638 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8661638  }}</ref>In 1890, [[virilization]] was first documented following resection of an [[Adrenal tumor|adrenal tumor.]]
* In 1890, [[virilization]] was first documented following resection of an [[Adrenal tumor|adrenal tumor.]]
* In 1893, Grawitz et al was the first one described ACC and falsely assumed it a hypernephroma.
* In 1893, Grawitz et al was the first one described ACC and falsely assumed it a hypernephroma.<ref name="pmid8661638">{{cite journal| author=Welbourn RB| title=Highlights from endocrine surgical history. | journal=World J Surg | year= 1996 | volume= 20 | issue= 5 | pages= 603-12 | pmid=8661638 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8661638  }}</ref>
* In 1934, Walters et al. described [[Cushing's syndrome]] in patients with [[Adrenal tumor|adrenal tumors]] and emphasized that the characteristic findings were not exclusively related to the [[Pituitary disease|pituitary disease.]]<ref name="pmid17856387">{{cite journal| author=Walters W, Wilder RM, Kepler EJ| title=THE SUPRARENAL CORTICAL SYNDROME WITH PRESENTATION OF TEN CASES. | journal=Ann Surg | year= 1934 | volume= 100 | issue= 4 | pages= 670-88 | pmid=17856387 | doi= | pmc=1390421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17856387  }}</ref>
* In 1934, Walters et al. described [[Cushing's syndrome]] in patients with [[Adrenal tumor|adrenal tumors]] and emphasized that the characteristic findings were not exclusively related to the [[Pituitary disease|pituitary disease.]]<ref name="pmid17856387">{{cite journal| author=Walters W, Wilder RM, Kepler EJ| title=THE SUPRARENAL CORTICAL SYNDROME WITH PRESENTATION OF TEN CASES. | journal=Ann Surg | year= 1934 | volume= 100 | issue= 4 | pages= 670-88 | pmid=17856387 | doi= | pmc=1390421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17856387  }}</ref>
* In 1899, Knowsly Thornton of London was the first surgeon to successfully remove an [[Adrenal cancer|adrenal cancer.]]
* In 1899, Knowsly Thornton of London was the first surgeon to successfully remove an [[Adrenal cancer|adrenal cancer.]]
Line 18: Line 18:
* Between 1930 and 1949, nearly 300 patients with ACC were published.
* Between 1930 and 1949, nearly 300 patients with ACC were published.
* In 1949, the first patient with [[Cushing's syndrome|Cushing’s disease]] treated with preoperative [[cortisol]].
* In 1949, the first patient with [[Cushing's syndrome|Cushing’s disease]] treated with preoperative [[cortisol]].
* By 1955, Tait and Simpson in London and Reichstein in Basel had isolated and prepared [[aldosterone]] for clinical use as [[Fludrocortisone|fludrocortisone.]]
* By 1957, an intravenous preparation of [[cortisol]], hydrocortisone, was used intraoperatively and in urgent situations of [[adrenal insufficiency]].<ref name="pmid13571886">{{cite journal| author=MACFARLANE DA| title=Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. | journal=Ann R Coll Surg Engl | year= 1958 | volume= 23 | issue= 3 | pages= 155-86 | pmid=13571886 | doi= | pmc=2413691 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13571886  }}</ref>
* By 1957, an intravenous preparation of [[cortisol]], hydrocortisone, was used intraoperatively and in urgent situations of [[adrenal insufficiency]].<ref name="pmid13571886">{{cite journal| author=MACFARLANE DA| title=Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. | journal=Ann R Coll Surg Engl | year= 1958 | volume= 23 | issue= 3 | pages= 155-86 | pmid=13571886 | doi= | pmc=2413691 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13571886  }}</ref>
* By 1955, Tait and Simpson in London and Reichstein in Basel had isolated and prepared [[aldosterone]] for clinical use as [[Fludrocortisone|fludrocortisone.]]
* In 1960, [[mitotane]] was first used clinically to treat inoperable or recurrent ACC.
* In 1960, [[mitotane]] was first used clinically to treat inoperable or recurrent ACC.



Revision as of 17:43, 22 September 2017

Adrenocortical carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenocortical carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

MRI

CT

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation Therapy

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Adrenocortical carcinoma historical perspective On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenocortical carcinoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenocortical carcinoma historical perspective

CDC on Adrenocortical carcinoma historical perspective

Adrenocortical carcinoma historical perspective in the news

Blogs on Adrenocortical carcinoma historical perspective

Hospitals Treating Adrenocortical carcinoma

Risk calculators and risk factors for Adrenocortical carcinoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

In 1893, Grawitz et al was the first one described ACC and falsely assumed it a hypernephroma. ByBy 1938, the Mayo group had removed tumors successfully from 16 consecutive patients, most of whom had Cushing’s syndrome. In 1960, mitotane was first used clinically to treat inoperable or recurrent ACC.

Historical perspective

References

  1. Welbourn RB (1996). "Highlights from endocrine surgical history". World J Surg. 20 (5): 603–12. PMID 8661638.
  2. Walters W, Wilder RM, Kepler EJ (1934). "THE SUPRARENAL CORTICAL SYNDROME WITH PRESENTATION OF TEN CASES". Ann Surg. 100 (4): 670–88. PMC 1390421. PMID 17856387.
  3. Klammer A, Morger R (1983). "Successful treatment of an adrenocortical carcinoma". Prog Pediatr Surg. 16: 117–20. PMID 6878723.
  4. RAPAPORT E, GOLDBERG MB, GORDAN GS, HINMAN F (1952). "Mortality in surgically treated adrenocortical tumors. II. Review of cases reported for the 20 year period 1930-1949, inclusive". Postgrad Med. 11 (4): 325–53. PMID 14920312.
  5. MACFARLANE DA (1958). "Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases". Ann R Coll Surg Engl. 23 (3): 155–86. PMC 2413691. PMID 13571886.